Authors: BES JC TKACZUK J CZECH KA TAFANI M BASTIDE R CARATERO C PAPPAS GD LAZORTHES Y

Citation: Jc. Bes et al., ONE-YEAR CHROMAFFIN CELL ALLOGRAFT SURVIVAL IN CANCER-PATIENTS WITH CHRONIC PAIN - MORPHOLOGICAL AND FUNCTIONAL EVIDENCE, Cell transplantation, 7(3), 1998, pp. 227-238

Authors: SALLERINCAUTE B LAZORTHES Y DEGUINE O FRANCES B VERDIE JC CHARLET JP BASTIDE R

Citation: B. Sallerincaute et al., DOES INTRATHECAL MORPHINE IN THE TREATMENT OF CANCER PAIN INDUCE THE DEVELOPMENT OF TOLERANCE, Neurosurgery, 42(1), 1998, pp. 44-49

Authors: PALANQUE P BASTIDE R

Citation: P. Palanque et R. Bastide, SYNERGISTIC MODELING OF TASKS, USERS AND SYSTEMS USING FORMAL SPECIFICATION TECHNIQUES, Interacting with computers, 9(2), 1997, pp. 129-153

Authors: HANAIREBROUTIN H SALLERINCAUTE B PONCET MF TAUBER M BASTIDE R ROSENFELD R TAUBER JP

Citation: H. Hanairebroutin et al., INSULIN THERAPY AND GH-IGF-I AXIS DISORDERS IN DIABETES - IMPACT OF GLYCEMIC CONTROL AND HEPATIC INSULINIZATION, Diabetes & metabolism, 22(4), 1996, pp. 245-250

Authors: HANAIREBROUTIN H SALLERINCAUTE B PONCET MF TAUBER M BASTIDE R CHALE JJ ROSENFELD R TAUBER JP

Citation: H. Hanairebroutin et al., EFFECT OF INTRAPERITONEAL INSULIN DELIVERY ON GROWTH-HORMONE BINDING-PROTEIN, INSULIN-LIKE GROWTH-FACTOR (IGF)-I, AND IGF-BINDING PROTEIN-3IN IDDM, Diabetologia, 39(12), 1996, pp. 1498-1504

Authors: TAUBER M DUPORTAL HD SALLERINCAUTE B ROCHICCIOLI P BASTIDE R

Citation: M. Tauber et al., DIFFERENTIAL REGULATION OF SERUM GROWTH-HORMONE (GH)-BINDING PROTEIN DURING CONTINUOUS-INFUSION VERSUS DAILY INJECTION OF RECOMBINANT HUMANGH IN GH-DEFICIENT CHILDREN, The Journal of clinical endocrinology and metabolism, 76(5), 1993, pp. 1135-1139